An explainable longitudinal multi-modal fusion model for predicting neoadjuvant therapy response in women with breast cancer.

Journal: Nature communications
PMID:

Abstract

Multi-modal image analysis using deep learning (DL) lays the foundation for neoadjuvant treatment (NAT) response monitoring. However, existing methods prioritize extracting multi-modal features to enhance predictive performance, with limited consideration on real-world clinical applicability, particularly in longitudinal NAT scenarios with multi-modal data. Here, we propose the Multi-modal Response Prediction (MRP) system, designed to mimic real-world physician assessments of NAT responses in breast cancer. To enhance feasibility, MRP integrates cross-modal knowledge mining and temporal information embedding strategy to handle missing modalities and remain less affected by different NAT settings. We validated MRP through multi-center studies and multinational reader studies. MRP exhibited comparable robustness to breast radiologists, outperforming humans in predicting pathological complete response in the Pre-NAT phase (ΔAUROC 14% and 10% on in-house and external datasets, respectively). Furthermore, we assessed MRP's clinical utility impact on treatment decision-making. MRP may have profound implications for enrolment into NAT trials and determining surgery extensiveness.

Authors

  • Yuan Gao
    Engineering Research Center of EMR and Intelligent Expert System, Ministry of Education, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, College of Biomedical Engineering and Instrument Science, Zhejiang University, Hangzhou Zhejiang Province, China.
  • Sofia Ventura-Diaz
    Department of Radiology, St Joseph's Healthcare Hamilton, 50 Charlton Ave E, Hamilton, ON L8N 4A6, Ontario, Canada.
  • Xin Wang
    Key Laboratory of Bio-based Material Science & Technology (Northeast Forestry University), Ministry of Education, Harbin 150040, China.
  • Muzhen He
    Department of Radiology, Shengli Clinical Medical College of Fujian Medical University, Fuzhou University Affiliated Provincial Hospital, Fuzhou, Fujian, 350001, China.
  • Zeyan Xu
    School of Medicine, South China University of Technology, Guangzhou 510006, China.
  • Arlene Weir
    Department of Radiology, Cork University Hospital, Wilton, Cork, T12 DC4A, Ireland.
  • Hong-Yu Zhou
    Department of Respiratory and Critical Care Medicine, National Clinical Research Center for Geriatrics, Frontiers Science Center for Disease-related Molecular Network, West China Hospital, Sichuan University, Chengdu 610041, P.R. China; Department of Computer Science, The University of Hong Kong, Pokfulam, Hong Kong.
  • Tianyu Zhang
    State Key Laboratory of Respiratory Disease, Joint School of Life Sciences, Guangzhou Chest Hospital, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou Medical University, Guangzhou, China.
  • Frederieke H van Duijnhoven
    Department of Surgery, the Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands.
  • Luyi Han
    College of Electrical Engineering and Information Technology, Sichuan University, Chengdu, 610065, China.
  • Xiaomei Li
    The Second Clinical Medical College of Jinan University, Shenzhen, Guangdong, 518020, China.
  • Anna D'Angelo
    Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
  • Valentina Longo
    Department of Diagnostic Imaging, Oncological Radiotherapy and Hematology, Fondazione Policlinico Universitario 'A. Gemelli' IRCCS, Rome, Italy.
  • Zaiyi Liu
    Department of Radiology, Guangdong Provincial People's Hospital (Guangdong Academy of Medical Sciences), Southern Medical University, Guangzhou, China.
  • Jonas Teuwen
    Department of Radiology and Nuclear Medicine, Radboud University Medical Center, PO Box 9101, 6500 HB, Nijmegen, The Netherlands.
  • Marleen Kok
    Department of Tumor Biology and Immunology, Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
  • Regina Beets-Tan
  • Hugo M Horlings
    The Netherlands Cancer Institute (NKI), Amsterdam, The Netherlands.
  • Tao Tan
    Faculty of Applied Sciences, Macao Polytechnic University, Macao, China.
  • Ritse Mann
    Diagnostic Image Analysis Group, Department of Radiology, Radboud University Medical Center, Nijmegen, The Netherlands.